Verdegaal EME, Verpoorte ALC, van der Kooij MK, de Bruin L, et al. Effective TIL therapy for patients with checkpoint-resistant melanoma without lymphodepleting regimens requires interferon-alpha. Clin Cancer Res 2025 May 6. doi: 10.1158/1078-0432.CCR-24-4322.
PMID: 40327337